← Back
$INO All transactions

INOVIO PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

78,760

Price

$0

Filed

Mar 5

Insider

Name

Shea Jacqueline Elizabeth

Title

Chief Executive Officer

CIK

0001771498

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-04

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

78,760

Footnotes

The vesting schedule for the 97,240 options granted on March 4, 2026 was as follows: 32,414 shares will vest on February 26, 2027; 32,413 shares will vest on February 26, 2028; 32,413 shares will vest on February 26, 2029. | Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Filing Info

Accession No.

0001771498-26-000003

Form Type

4

Issuer CIK

0001055726

Shea Jacqueline Elizabeth's History

Date Ticker Type Value
2026-03-04 INO A $0
2026-03-04 INO A $0
2026-02-26 INO M
2026-02-26 INO F $14K
2026-02-26 INO M
2026-02-26 INO F $24K
2026-02-26 INO M $0
2026-02-26 INO M $0
2025-05-20 INO A $0
2025-05-20 INO A $0

Other Insiders at INO (90d)

Insider Bought Sold Last
KIES PETER
CFO
2026-03-04
Weiner David B. 2026-02-26
Humeau Laurent
Chief Scientific Officer
2026-03-04
Shea Jacqueline Elizabeth
Chief Executive Officer
2026-03-04
Sumner Michael John
Chief Medical Officer
2026-03-31